Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of cyclin‐dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway
Shen Shen, Dylan C. Dean, Zujiang Yu, et al.
Hepatology Research (2019) Vol. 49, Iss. 10, pp. 1097-1108
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Targeted therapy for hepatocellular carcinoma
Ao Huang, Xin‐Rong Yang, Wen Yuan Chung, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 538
CDK inhibitors from past to present: A new wave of cancer therapy
Muhammad Jameel, Kinjal Bhadresha, Hang Fai Kwok
Seminars in Cancer Biology (2022) Vol. 88, pp. 106-122
Open Access | Times Cited: 57
CDK regulators—Cell cycle progression or apoptosis—Scenarios in normal cells and cancerous cells
Nilmani, Maria D'costa, Anusha Bothe, et al.
Advances in protein chemistry and structural biology (2023), pp. 125-177
Closed Access | Times Cited: 29
Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
Jiajun Li, Yanyan Yan, Hongmei Sun, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 60
Development of PROTAC degrader probe of CDK4/6 based on DCAF16
Chunlan Pu, Yuanyuan Liu, Rui Deng, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106637-106637
Closed Access | Times Cited: 18
DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity
Y. Liu, Zhenkang Li, Jinchao Zhang, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 243-257
Closed Access | Times Cited: 6
CDK1 dependent phosphorylation of hTERT contributes to cancer progression
Mami Yasukawa, Yoshinari Ando, Taro Yamashita, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 49
New landscapes and horizons in hepatocellular carcinoma therapy
Melchiorre Cervello, Maria Rita Emma, Giuseppa Augello, et al.
Aging (2020) Vol. 12, Iss. 3, pp. 3053-3094
Open Access | Times Cited: 48
Small molecule ‘4ab’ induced autophagy and endoplasmic reticulum stress-mediated death of aggressive cancer cells grown under adherent and floating conditions
Sameer Ullah Khan, Kaneez Fatima, Umed Singh, et al.
Medical Oncology (2023) Vol. 40, Iss. 4
Closed Access | Times Cited: 16
In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies
Mohamed Moussaoui, Mouna Baassi, Soukayna Baammi, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 23, pp. 13646-13662
Closed Access | Times Cited: 15
Cyclin-dependent kinase 4 and 6 in cancer: Exploration of CDK4/6 inhibitors as anticancer agents
Nilay Kumar Nandi, Chahat, Rohit Bhatia, et al.
Elsevier eBooks (2024), pp. 115-137
Closed Access | Times Cited: 4
Super-enhancers in hepatocellular carcinoma: regulatory mechanism and therapeutic targets
Xuejin Lu, Meizi Zhu, Xueliang Pei, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Hepatorenoprotective effects of Lepidium draba L. extracts against cyclophosphamide-induced oxidative injuries in rats via reducing apoptosis and inflammation
Yulai You, Sheng Zheng, Chengjian Zhao, et al.
Asian Pacific Journal of Tropical Biomedicine (2025) Vol. 15, Iss. 2, pp. 53-64
Open Access
Pharmacoproteomics Identifies Kinase Pathways that Drive the Epithelial-Mesenchymal Transition and Drug Resistance in Hepatocellular Carcinoma
Martin Golkowski, Ho-Tak Lau, Marina Chan, et al.
Cell Systems (2020) Vol. 11, Iss. 2, pp. 196-207.e7
Open Access | Times Cited: 32
Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma
Yizhou Wang, Feihong Song, Xiaofeng Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-28
Open Access | Times Cited: 17
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines
Graziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 24
Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma
Enakshi Sivasudhan, Neil Blake, Zhi-Liang Lu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 17
Identification and validation of the N6-methyladenosine RNA methylation regulator ZC3H13 as a novel prognostic marker and potential target for hepatocellular carcinoma
Shuang Wu, Guifang He, Shihai Liu, et al.
International Journal of Medical Sciences (2022) Vol. 19, Iss. 4, pp. 618-630
Open Access | Times Cited: 11
Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays
Faten Farouk, Ibrahim M. Ibrahim, Salma Sherif, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 3
Closed Access | Times Cited: 2
Anti-hepatocellular carcinoma activity of the cyclin-dependent kinase inhibitor AT7519
Kaja Karaś, Iwona Karwaciak, Katarzyna Chałaśkiewicz, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 115002-115002
Open Access | Times Cited: 6
Omethoate induces pharyngeal cancer cell proliferation and G1/S cell cycle progression by activation of Akt/GSK-3β/cyclin D1 signaling pathway
Dongdong Huo, Shulong Jiang, Zhenjie Qin, et al.
Toxicology (2019) Vol. 427, pp. 152298-152298
Closed Access | Times Cited: 16
A Computational approach to discover potential quinazoline derivatives against CDK4/6 kinase
Arjun Anant, Amena Ali, Abuzer Ali, et al.
Journal of Molecular Structure (2021) Vol. 1245, pp. 131079-131079
Closed Access | Times Cited: 14
CBX3 regulated by miR-139 promotes the development of HCC by regulating cell cycle progression
Pan Zhang, Xiaoyan Yang, Zhongming Zha, et al.
Cell Cycle (2022) Vol. 21, Iss. 16, pp. 1740-1752
Open Access | Times Cited: 9
Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway
Tianying Cai, Junjie Bai, Peng Tan, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 5, pp. 805-817
Open Access | Times Cited: 5
Involvement of CDK11B-mediated SPDEF ubiquitination and SPDEF-mediated microRNA-448 activation in the oncogenicity and self-renewal of hepatocellular carcinoma stem cells
Juncheng Guo, Yijun Yang, Min Guo, et al.
Cancer Gene Therapy (2020) Vol. 28, Iss. 10-11, pp. 1136-1149
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top